$INKT

$12.93▲ +2.0% YTD

2 SEC 13D/G filings tracked · Last updated Oct 2, 2026

Filing History

CP $12.93▲ +2.0%Oct 2, 2026 · ThinkSabio Blog

$INKT - MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026…

News

INKT ▼ -1.2% - MiNK Therapeutics, Inc.

CP $12.11▲ -1.2%Sep 30, 2026 · ThinkSabio Blog

$INKT - MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy…